China has authorized the emergency use of a Covid-19 vaccine for kids as young as three, the drug-making industry confirmed on Tuesday, making China the first country to offer jabs to young children.
“In recent days, the Sinovac vaccine was approved for emergency use in three- to 17-year-olds,” a spokesperson for sinovac confirmed.
But his declaration did not confirm when the young kids would be eligible to start acquiring the shots. He said that the schedule for the rollout will be decided by the National Health Commission as per China’s recent epidemic prevention and control necessities and vaccine stock.
The company has finalized early phase trials of the vaccine in children and adolescents, with results to be published soon in the Lancet scientific journal.
A spokesperson for China’s other major vaccine- Sinopharm, said that specialists had indicated the cogency of its vaccine in children, but didn’t confirm whether it had been certified for use.
While the WHO does not currently propose vaccinating children against coronavirus, the United States, Britain, Singapore, and the European Union have already authorized the Pfizer-BioNTech vaccine for kids as young as 12.
Children have been greatly limited to the worst of the pandemic, becoming infected less easily than adults and normally exhibiting less drastic symptoms when they do catch the virus.
But experts say children can still deliver the virus to others and some said that if countries are going to achieve herd immunity through their vaccination campaigns, inoculating children should be part of the plan.
“Vaccinating children is an important step forward,” said Jin Dong-yan, a virologist at the University of Hong Kong’s medical school.
The World Health Organization (WHO) has approved both the Sinopharm and Sinovac vaccines for emergency use in adults aged 18 and older, and both jabs are being administered in several countries around the globe.
If China is to meet its indecisive expectation of vaccinating 80% of its population against the coronavirus by the end of the year, tens of millions of children may have to begin rolling up their sleeves.
Controllers took the initial step last week by authorizing the use of the country’s Sinovac vaccine for kids aged 3 to 17, and on Friday announced the same for the Sinopharm vaccine. No finalized date has been established for the shots to initiate.